Dag Berild
-
- Antibiotic Use and Resistance 30
- Parasitology top 5%
- Clinical Biochemistry top 5%
- Bacterial Identification and Susceptibility Testing 6
- Molecular Medicine top 10%
- Epidemiology top 10%
- Pneumonia and Respiratory Infections 16
-
- Antibiotics Pharmacokinetics and Efficacy 8
-
- Neonatal and Maternal Infections 7
-
- Myeloproliferative Neoplasms: Diagnosis and Treatment 6
-
- Patient Satisfaction in Healthcare 5
-
- Gut microbiota and health 5
Dag Berild
79 papers receiving 924 citations
Peers
Comparison fields: 5 of 117
- Applied Microbiology and Biotechnology 308
- Parasitology 94
- Clinical Biochemistry 88
- Molecular Medicine 64
- Epidemiology 348
Countries citing papers authored by Dag Berild
This map shows the geographic impact of Dag Berild's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dag Berild with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dag Berild more than expected).
Fields of papers citing papers by Dag Berild
This network shows the impact of papers produced by Dag Berild. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dag Berild. The network helps show where Dag Berild may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dag Berild, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 0 | |
| 4 | 2022 | 20 | |
| 5 | 2020 | 31 | |
| 6 | 2019 | 3 | |
| 7 | 2018 | 14 | |
| 8 | 2015 | 23 | |
| 9 | 2014 | 12 | |
| 10 | 2011 | 16 | |
| 11 | 2011 | 17 | |
| 12 | Fornuftig bruk av antibiotika i sykehus | 2008 | 2 |
| 13 | 2008 | 15 | |
| 14 | 2006 | 29 | |
| 15 | Bruk av systemiske antibiotika ved et norsk sykehjem | 2002 | 3 |
| 16 | 2002 | 8 | |
| 17 | Influence of prescription patterns in general practice on anti-microbial resistance in Norway. | 1999 | 31 |
| 18 | 1994 | 3 | |
| 19 | 1992 | 7 | |
| 20 | 1990 | 6 |
About Dag Berild
Dag Berild is a scholar working on Applied Microbiology and Biotechnology, Clinical Biochemistry and Epidemiology, having authored 83 papers that have together received 961 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (30 papers), Pneumonia and Respiratory Infections (16 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers), Neonatal and Maternal Infections (7 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Bacterial Identification and Susceptibility Testing (6 papers), Patient Satisfaction in Healthcare (5 papers) and Gut microbiota and health (5 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (308 citations), Parasitology (94 citations) and Clinical Biochemistry (88 citations). Dag Berild has collaborated with scholars based in Norway, Denmark and Sweden. Frequent co-authors include S Ringertz, Morten Lindbæk, Hans Carl Hasselbalch, Mogens Jensenius, Harald Reiso, Jon Birger Haug, Mark J. Fagan, Pierre Bouchelouche, Per Hjortdahl and Fernanda C. Petersen. Their work appears in journals such as Infectious Diseases, Scandinavian Journal of Clinical and Laboratory Investigation, BMC Infectious Diseases, Journal of Antimicrobial Chemotherapy and Scandinavian Journal of Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.